Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) EBIT Margin (2024 - 2025)

Incannex Healthcare (IXHL) has disclosed EBIT Margin for 2 consecutive years, with 139900.0% as the latest value for Q4 2025.

  • Quarterly EBIT Margin fell 9820000.0% to 139900.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 263200.0% through Dec 2025, down 23015698.0% year-over-year, with the annual reading at 27661.63% for FY2025, 22268004.0% up from the prior year.
  • EBIT Margin hit 139900.0% in Q4 2025 for Incannex Healthcare, down from 135880.0% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 8451.35% in Q3 2024 to a low of 139900.0% in Q4 2025.